Predicting significance of EGFR mutation existing in tissues and plasma concuurrently or alone to EGFR–tyrosine kinase inhibitors (EGFR-TKIs) for advanced non-small cell lung cancer.
Yuyan Wang
No relevant relationships to disclose
Jie Wang
Research Funding - National Science Foundation for Distinguished Young Scholars of China
Hua Bai
Research Funding - National Natural Science Foundation of China
Zhijie Wang
Research Funding - National Natural Science Foundation of China
Jianchun Duan
No relevant relationships to disclose
Tongtong An
No relevant relationships to disclose
Jun Zhao
No relevant relationships to disclose
Minglei Zhuo
No relevant relationships to disclose
Meina Wu
No relevant relationships to disclose
Shuhang Wang
Research Funding - National Natural Science Foundation of China